Publications by authors named "Hanna Bitner"

Claim this Profile
T
The mTOR inhibitor everolimus overcomes CXCR4-mediated resistance to histone deacetylase inhibitor panobinostat through inhibition of p21 and mitotic regulators.
Katia Beider, Hanna Bitner, Valeria Voevoda-Dimenshtein, Evgenia Rosenberg, Yaarit Sirovsky

Biochem Pharmacol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissecting the mechanisms involved in anti-human T-lymphocyte immunoglobulin (ATG)-induced tolerance in the setting of allogeneic stem cell transplantation - potential implications for graft versus host disease.
Katia Beider, David Naor, Valeria Voevoda, Olga Ostrovsky, Hanna Bitner

Oncotarget· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 Pathway.
Katia Beider, Evgenia Rosenberg, Hanna Bitner, Avichai Shimoni, Merav Leiba

Clin Cancer Res· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype.
Katia Beider, Hanna Bitner, Merav Leiba, Odit Gutwein, Maya Koren-Michowitz

Oncotarget· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency, genotype, and clinical spectrum of best vitelliform macular dystrophy: data from a national center in Denmark.
Hanna Bitner, Patrik Schatz, Liliana Mizrahi-Meissonnier, Dror Sharon, Thomas Rosenberg

Am J Ophthalmol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A homozygous frameshift mutation in BEST1 causes the classical form of Best disease in an autosomal recessive mode.
Hanna Bitner, Liliana Mizrahi-Meissonnier, Gabriel Griefner, Inbar Erdinest, Dror Sharon

Invest Ophthalmol Vis Sci· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of macular structure and function by OCT and electrophysiology in patients with vitelliform macular dystrophy due to mutations in BEST1.
Patrik Schatz, Hanna Bitner, Birgit Sander, Stig Holfort, Sten Andreasson

Invest Ophthalmol Vis Sci· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis